| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Expression profiling by high throughput sequencing
|
TAR
|
May 24, 2023
|
|||||
| GSE210155 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity
|
|
25 |
|
Hongbo Chi | May 24, 2023 | ||
| GSE210153 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 1]
|
|
4 |
|
Hongbo Chi | May 24, 2023 | ||
| GSE210154 |
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 2]
|
|
8 |
|
Hongbo Chi | May 24, 2023 | ||
| GSE218985 |
CRISPR-based epigenome editing screens identify transcriptional and epigenetic regulators of human CD8 T cell function [CRISPRi/a TF scRNA-seq characterization]
|
|
6 |
|
Sean McCutcheon | May 24, 2023 | ||
| GSE218988 |
CRISPR-based epigenome editing screens identify transcriptional and epigenetic regulators of human CD8 T cell function
|
|
75 |
|
Sean McCutcheon | May 24, 2023 |
